NEW YORK, Jan. 17, 2017 -- TransPerfect, a leading provider of global development and commercialization solutions to the life sciences industry, today announced that Chesapeake IRB has integrated its IRB platform with the Trial Interactive electronic Trial Master File (eTMF) and study start-up solution to streamline global trial management for sponsors and CROs.
Trial Interactive is a web-based, 21 CFR Part 11-compliant platform that eliminates the redundancies inherent in paper-based study start-up and TMF management. By providing real-time access to clinical trial documentation as well as automated status notifications for protocols and investigative sites, the integration reduces the time and costs of manually managing IRB-related documentation.
CIRBI (Center for IRB Intelligence) is Chesapeake IRB’s completely paperless, cloud-based, 21 CFR Part 11-compliant protocol submission and management platform. CIRBI streamlines electronic submissions for all IRB actions and provides complete and rapid delivery of all IRB data and artifacts through its advanced IRB-CONNECT™ technology.
Michael Smyth, General Manager of TransPerfect Life Sciences Solutions, stated, “We have daily interaction with our eTMF and study start-up clients who use or are planning to use Chesapeake IRB as their central IRB. We have had an ongoing commitment to eliminate inefficiencies in the conduct of clinical trials and the IRB documentation that needs to be rapidly available to allow for faster site activation and ultimately wind up in the TMF is critical. This process to date is still fairly inefficient requiring a lot of manual work and we were easily able to collaborate with Chesapeake, due to their state-of-the-art platform, to eliminate this manual process of getting thousands of documents seamlessly into the Trial Interactive eTMF for our mutual clients.”
“Many of Chesapeake’s clients are moving to an eTMF environment and want an efficient way to have IRB-related documents automatically transferred into the eTMF with relevant metadata for auto-filing in the right place in real time without a tedious and error-prone process. Integration with Trial Interactive is a great benefit to our mutual and potential clients using the eTMF solution,” said Jeffrey Wendel, President and CEO of Chesapeake IRB. “With its paperless process and global document management capabilities, Trial Interactive helps our customers streamline site activation and accelerate start-up timelines while meeting regulatory requirements and facilitating remote inspections. It’s a win for the life sciences industry.”
TransPerfect Co-CEO Phil Shawe stated, “Chesapeake IRB has a sterling reputation, and the shared attributes between CIRBI and Trial Interactive represented a significant opportunity for us to collaborate. The result is a robust, paperless solution with a wide range of applications that will help us to deliver greater value to our clients.”
Liz Elting, Co-CEO of TransPerfect, added, “Any opportunity to make things easier on our clients is something we welcome with open arms. In this case, we’ve been able to work with Chesapeake to produce an integrated solution that will be a game changer in the eTMF and IRB world, and we’re confident that the time and cost savings will be both immediate and significant.”
About Chesapeake IRB
Chesapeake IRB, an AAHRPP-accredited company, provides independent IRB submission and review services to pharmaceutical, biotech and medical device companies as well as academic medical centers and hospital systems. Its paperless, cloud-based submission and review platform, CIRBI, leads the field and has set the standard in review turnaround time, quality and document accessibility. Headquartered in Columbia, Md., Chesapeake IRB has offices across the United States and a wholly owned subsidiary, IRB Services, with offices in Toronto and Montreal, Canada. Visit chesapeakeirb.com for more information.
About TransPerfect
With annual revenues of more than $540 million, TransPerfect is the world's largest privately held provider of language services and technology solutions. From offices in over 90 cities on six continents, TransPerfect offers a full range of services in 170+ languages to clients worldwide. More than 3,000 global organizations employ TransPerfect’s GlobalLink® Product Suite to simplify management of multilingual content. With an unparalleled commitment to quality and client service, TransPerfect is fully ISO 9001 and ISO 17100 certified. TransPerfect has global headquarters in New York, with regional headquarters in London and Hong Kong. For more information, please visit our website at www.transperfect.com.
Contact: Ryan Simper +1 212.689.5555 [email protected]


Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 



